NorthWest Biotherapeutics Inc (NWBO)

[georgebailey]

No 100% disagree. What’s important to shareholders are milestones achieved such as MHRA approval not the date of the ASM.
Second, what’s important to shareholders is effective communications including target dates for milestones.
Whether they hit target dates is a separate discussion.
Third, they can hold the ASM regardless of whether approval is in hand. We have words like imminent to use should ASM precede approval. Besides, there are other milestones besides approval that are relevant like Eden’s readiness and target date for device approval.
Last, per PRs or the 10k we learned that once the MHRA process has been cemented there’s material collaborations involving additional trials or other. LP also indicated that the sole focus will be on the MHRA process and nothing else.
So to me, there is no other resources to devote to anything but the approval process. Since this is an available time issue and an ASM is announced then time resources have become available and the infamous cement has cured.
My opinion is better than yours LoL.